| Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer (NCT00238290) | Swiss Cancer Institute | 2005-05-01 |
| Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer (NCT00217672) | Translational Oncology Research International | 2005-05-01 |
| Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer (NCT00430001) | Danish Breast Cancer Cooperative Group | 2005-05-01 |
| A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together (NCT00618124) | Pfizer | 2005-05-01 |
| Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation (NCT00287898) | Georgetown University | 2005-05-01 |
| Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk (NCT01559194) | Ohio State University Comprehensive Cancer Center | 2005-05-01 |
| Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET (NCT00904410) | Centre Oscar Lambret | 2005-05-01 |
| Delayed-Immediate Breast Reconstruction (NCT00473122) | M.D. Anderson Cancer Center | 2005-04-01 |
| A Prevention Trial in Subjects at High Risk for Breast Cancer (NCT01500577) | European Institute of Oncology | 2005-04-01 |
| Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer (NCT00138125) | Translational Oncology Research International | 2005-04-01 |
| Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer (NCT00118053) | University of Medicine and Dentistry of New Jersey | 2005-04-01 |
| Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy (NCT01016665) | Federal University of São Paulo | 2005-04-01 |
| Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 (NCT00343616) | ETOP IBCSG Partners Foundation | 2005-04-01 |
| Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer (NCT00463034) | University of Sheffield | 2005-04-01 |
| Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study (NCT00188591) | University Health Network, Toronto | 2005-04-01 |
| Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer (NCT00114296) | Cedars-Sinai Medical Center | 2005-04-01 |
| Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer (NCT00106002) | Eli Lilly and Company | 2005-04-01 |
| Use of Breast MRI for Local Staging (NCT00579319) | University of Arkansas | 2005-04-01 |
| Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer (NCT00286819) | Central European Cooperative Oncology Group | 2005-04-01 |
| A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer (NCT00428896) | University Hospital of Crete | 2005-04-01 |
| Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 (NCT00899288) | ETOP IBCSG Partners Foundation | 2005-04-01 |
| Iodine Supplementation on Breast Cancer (NCT03688958) | Universidad Nacional Autonoma de Mexico | 2005-03-15 |
| Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease (NCT00312637) | UNC Lineberger Comprehensive Cancer Center | 2005-03-01 |
| Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer (NCT00587925) | Memorial Sloan Kettering Cancer Center | 2005-03-01 |
| Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response (NCT02280252) | NYU Langone Health | 2005-03-01 |
| Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection (NCT00195026) | Weill Medical College of Cornell University | 2005-03-01 |
| Study of GPX-100 in the Treatment of Metastatic Breast Cancer (NCT00123877) | Gem Pharmaceuticals | 2005-03-01 |
| Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer (NCT00107094) | Celgene Corporation | 2005-03-01 |
| Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation (NCT02104895) | Azienda Ospedaliero-Universitaria Careggi | 2005-03-01 |
| Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) (NCT00196846) | GBG Forschungs GmbH | 2005-03-01 |
| Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line (NCT00191854) | Eli Lilly and Company | 2005-03-01 |
| MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer (NCT00373152) | Masonic Cancer Center, University of Minnesota | 2005-03-01 |
| Histologic Diagnoses of Incidentally Detected Lesions on MRI (NCT00579735) | University of Arkansas | 2005-03-01 |
| Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer (NCT00103181) | NSABP Foundation Inc | 2005-03-01 |
| Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer (NCT00201760) | Kari Kendra | 2005-02-25 |
| Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy (NCT02606708) | NYU Langone Health | 2005-02-20 |
| Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. (NCT00099437) | AstraZeneca | 2005-02-13 |
| Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases (NCT00617539) | University of California, San Francisco | 2005-02-01 |
| Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer (NCT00112749) | Jonsson Comprehensive Cancer Center | 2005-02-01 |
| Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer (NCT00309556) | Austrian Breast & Colorectal Cancer Study Group | 2005-02-01 |
| Aging and Cancer Effects (ACE) Study (NCT00204880) | University of Wisconsin, Madison | 2005-02-01 |
| Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer (NCT00352872) | Indiana University | 2005-02-01 |
| PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) (NCT00201942) | Ontario Clinical Oncology Group (OCOG) | 2005-02-01 |
| Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting (NCT01440855) | Fox Chase Cancer Center | 2005-02-01 |
| Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer (NCT00090974) | Eastern Cooperative Oncology Group | 2005-01-26 |
| Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study (NCT00341159) | National Human Genome Research Institute (NHGRI) | 2005-01-18 |
| Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight (NCT00343434) | Wake Forest University Health Sciences | 2005-01-01 |
| IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer (NCT00100893) | City of Hope Medical Center | 2005-01-01 |
| Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer (NCT00107263) | Alliance for Clinical Trials in Oncology | 2005-01-01 |
| PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer (NCT00216047) | Hoosier Cancer Research Network | 2005-01-01 |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer (NCT00599989) | Abramson Cancer Center at Penn Medicine | 2005-01-01 |
| Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends (NCT00896818) | Cancer Research UK | 2005-01-01 |
| Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy (NCT00909649) | Mansoura University | 2005-01-01 |
| Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00288002) | GBG Forschungs GmbH | 2005-01-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast (NCT00107211) | Abramson Cancer Center at Penn Medicine | 2005-01-01 |
| Iressa Follow-up Trial (NCT00357734) | AstraZeneca | 2005-01-01 |
| A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers (NCT00122239) | AHS Cancer Control Alberta | 2005-01-01 |
| The Role of Diet and Lifestyle in Breast Cancer Survival (NCT00701584) | University College London Hospitals | 2005-01-01 |
| Intraoperative Pathway in DIEP Flap Breast Reconstruction (NCT00543764) | Beth Israel Deaconess Medical Center | 2005-01-01 |
| Hypercoagulability After Breast Cancer Surgery (NCT00210197) | Institut Bergonié | 2005-01-01 |
| Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study (NCT00359060) | UMC Utrecht | 2005-01-01 |
| Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer (NCT00208273) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-01-01 |
| Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer (NCT00123929) | Hospital San Carlos, Madrid | 2005-01-01 |
| Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer (NCT00533780) | Stanford University | 2005-01-01 |
| Aromatase Inhibitor Clinical Trial (NCT00228956) | National Institute of General Medical Sciences (NIGMS) | 2005-01-01 |
| Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer (NCT00070278) | Cambridge University Hospitals NHS Foundation Trust | 2005-01-01 |
| Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer (NCT00691509) | University College London Hospitals | 2005-01-01 |
| Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer (NCT00900133) | Case Comprehensive Cancer Center | 2005-01-01 |
| Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer (NCT00602108) | Mayo Clinic | 2005-01-01 |
| Statins and Breast Cancer Biomarkers (NCT00914017) | University of Vermont | 2005-01-01 |
| Role of Gene Variation in Effectiveness of Gleevec Treatment (NCT00342056) | National Cancer Institute (NCI) | 2005-01-01 |
| Weight Reduction Intervention for Breast Cancer Survivors (NCT00774371) | University of California, San Diego | 2005-01-01 |
| Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer (NCT00083174) | NCIC Clinical Trials Group | 2004-12-03 |
| Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer (NCT00103233) | SWOG Cancer Research Network | 2004-12-01 |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer (NCT00559858) | Cambridge University Hospitals NHS Foundation Trust | 2004-12-01 |
| Psychosocial Impact of Cancer-Related Female Infertility (NCT00386217) | M.D. Anderson Cancer Center | 2004-12-01 |
| A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) (NCT00126451) | Merck Sharp & Dohme LLC | 2004-12-01 |
| An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall (NCT00208871) | Emory University | 2004-12-01 |
| Markers for Breast Cancer (NCT00339248) | National Cancer Institute (NCI) | 2004-12-01 |
| Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy (NCT00512993) | GBG Forschungs GmbH | 2004-12-01 |
| Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility (NCT00591851) | Memorial Sloan Kettering Cancer Center | 2004-12-01 |
| Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy (NCT00129597) | Hospices Civils de Lyon | 2004-12-01 |
| Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer (NCT00088998) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women (NCT00470119) | Fred Hutchinson Cancer Center | 2004-12-01 |
| Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy (NCT00754845) | Canadian Cancer Trials Group | 2004-11-23 |
| Evaluation of Breast CT (NCT00584233) | University of California, Davis | 2004-11-22 |
| Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00295867) | University of California, San Francisco | 2004-11-03 |
| Radiologic Evaluation and Breast Density (READ) (NCT00117663) | Kaiser Permanente | 2004-11-01 |
| Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy (NCT00581529) | University of Michigan Rogel Cancer Center | 2004-11-01 |
| Expanding Rural Access: Distance Delivery of Support (NCT00186511) | Stanford University | 2004-11-01 |
| FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole (NCT00199134) | Jules Bordet Institute | 2004-11-01 |
| Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy (NCT00087399) | Alliance for Clinical Trials in Oncology | 2004-11-01 |
| Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers (NCT00095862) | Wiseman Research Initiatives LLC | 2004-11-01 |
| Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) (NCT00784849) | Louisiana State University Health Sciences Center in New Orleans | 2004-11-01 |
| Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast (NCT00126464) | Cedars-Sinai Medical Center | 2004-11-01 |
| Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility (NCT00617370) | Memorial Sloan Kettering Cancer Center | 2004-11-01 |
| S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women (NCT00088972) | SWOG Cancer Research Network | 2004-11-01 |
| APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer (NCT00402519) | University of Erlangen-Nürnberg Medical School | 2004-11-01 |
| Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer (NCT00489125) | Wake Forest University Health Sciences | 2004-10-15 |